Sage Journals: Discover world-class research

Abstract

Credit

This lesson is good for 0.2 CE units, with a passing grade of 70%.

Objectives

After completing this continuing education article, the pharmacist will be able to:

1. Describe the evolution of immunization over the past thousand years.

2. Discuss the impact of specific infectious diseases on world populations before the development of immunizations against them.

3. Understand the significance of immunization in increasing human lifespan.

3. Compare immunization policies of different eras in the 20th century.

4. Identify some potential new applications of immunological drugs in the 21st century.

Keywords

diphtheria immunization influenza life expectancy pneumonia smallpox tetanus vaccination variolation

Get full access to this article

View all access options for this article.

References

Parish

H.J.

A History of Immunization. Edinburgh, U.K.: E & S Livingstone, Ltd; 1965.

Anonymous. A century of medical milestones. Washington Post. 1999(Dec 21): 8–9.

Anonymous. A world churning with success charges toward new challenges. USA Today. 1999; (Dec 31): 29A.

Anonymous. The four horsemen of the apolcalypse. USA Today. 1999; (Dec 31): 9a.

Wilson

A century of science. Popular Mechanics. 2000; 177(Jan): 64–83.

Nuland

S.B.

Heroes of medicine. Time. 1997; 150: 6–10.

Sheed

Virologist Jonas Salk. Time. 1999; 153(Mar 29): 168–70.

Newton

Story of the century. USA Weekend. 1999(Dec 24–25): 6–11.

Armstrong

G.L.

, Conn

L.A.

, Pinner

R.W.

Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999; 281: 61–6.

10.

Grabenstein

J.D.

Pandemic influenza: Planning now to avoid another tragedy. Hosp Pharm. 1999; 34: 845–6, 849–51,855–6.

11.

McKinlay

J.B.

, McKinlay

S.M.

The questionable contribution of medical measures to the decline of mortality in the United States in the twentieth century. Milbank Mem Fund Quarterly. 1977; 55: 405–28.

12.

McGinnis

J.M.

, Foege

W.H.

Actual causes of death in the United States. JAMA. 1993; 270: 2207–12.

13.

Bunker

J.P.

, Frazier

H.S.

, Mosteller

Improving health: measuring effects of medical care. Milbank Quarterly. 1994; 72: 225–58.

14.

Bunker

J.P.

Medicine matters after all. J Roy Col Phys London. 1995; 29: 105–12.

15.

Ryan

The Forgotten Plague: How the Battle Against Tuberculosis Was Won—And Lost. Boston: Little, Brown & Co.; 1993.

16.

Grabenstein

J.D.

Milestones in immunologic history: Antiquity to 1919. Hosp Pharm. 1994; 29: 477–8, 480–3.

17.

Grabenstein

J.D.

Milestones in immunologic history: 1920 to 1959. Hosp Pharm. 1994; 29: 621–2, 625–6,629–31.

18.

Grabenstein

J.D.

Milestones in immunologic history: 1960 to 1994. Hosp Pharm. 1994; 29: 712–6, 719–20.

19.

Plotkin

S.L.

, Plotkin

S.A.

A short history of vaccination. In: Plotkin

S.A.

, Orenstein

W.A.

, ed. Vaccines. 3rd ed. Philadelphia: WB Saunders; 1999, 1–12.

20.

Fenner

Henderson

, Arita

, Je_ek

, Ladnyi

. Smallpox and Its Eradication. Geneva: World Health Organization; 1988.

21.

Bollet

A.J.

The history of smallpox and its influence on military campaigns: Part 1. Resident Staff Phys. 1988; 34(3): 135–40.

22.

Benenson

A.S.

Immunization and military medicine. Rev Infect Dis 1984; 6: 1–12.

23.

Cowan

D.L.

Medicine and Health in New Jersey: A History. Princeton, NJ: Van Nostrand Co.; 1964, 3.

24.

Alexander

H.M.

Vaccine virus. Pharm Era. 1894; 11: 156–8.

25.

Chase

Magic Shots. New York: William Morrow; 1982.

26.

Centers for Disease Control. A centennial celebration: Pasteur and the modern era of immunization. MMWR. 1985; 34: 389–90.

27.

Kondratas

R.A.

The biologics control act of 1902. In: Young

J.H.

, ed. The Early Years of Federal Food and Drug Control. Madison, WI: American Institute of the History of Pharmacy; 1982, 8–27.

28.

Lévy

F.M.

A corner of history: The fiftieth anniversary of diphtheria and tetanus immunization. Prevent Med. 1975; 4: 226–37.

29.

English

P.C.

Diphtheria and theories of infectious disease: Centennial appreciation of the critical role of diphtheria in the history of medicine. Pediatrics. 1985; 76: 1–9.

30.

Austrian

Random gleanings from a life with the pneumococcus. J Infect Dis. 1975; 131: 474–84.

31.

McCue

J.P.

, Hein

R.H.

, Tenold

Three generations of immunoglobulin G preparations for clinical use. Rev Infect Dis. 1986; 8(suppl 4): S374–81.

32.

English

P.C.

Therapeutic strategies to combat pneumococcal disease: Repeated failure of physicians to adopt pneumococcal vaccine, 1900–1945. Perspect Biol Med. 1987; 30: 170–85.

33.

Smith

J.S.

Patenting the Sun: Polio and the Salk Vaccine. New York: William Morrow & Co.; 1990.

34.

Nathanson

, Langmuir

A.D.

The Cutter incident: Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. Am J Hyg. 1963; 78: 16–81.

35.

Bloch

A.B.

, Orenstein

W.A.

, Stetler

H.C.

Health impact of measles vaccination in the United States. Pediatrics. 1985; 76: 524–32.

36.

Hilleman

M.R.

Past, present, and future of measles, mumps, and rubella virus vaccines. Pediatrics. 1992; 90: 149–53.

37.

Cooper

L.Z.

The history and medical consequences of rubella. Rev Infect Dis. 1985; 7(suppl 1): S2–10.

38.

Plotkin

S.A.

, Clark

H.F.

Prevention of rabies in man. J Infect Dis. 1971; 123: 227–40.

39.

Grabenstein

J.D.

How do the Haemophilus vaccines vary?

Hosp Pharm. 1992; 27: 41–5, 48–9.

40.

Gangarosa

E.J.

, Galazka

A.M.

, Wolfe

C.R.

Impact of anti-vaccine movements on pertussis control: The untold story. Lancet. 1998; 351: 356–61.

41.

Grabenstein

J.D.

Pertussis (Part 1): A preventable threat, despite controversy. Hosp Pharm. 1997; 32: 1002, 1005–8,1011–2.

42.

Grabenstein

J.D.

ImmunoFacts: Vaccines and Immunologic Drugs. 19th revision. Saint Louis, MO: Facts & Comparisons, Inc.; May 2000.

43.

Neustadt

R.E.

, Fineberg

H.V.

The Epidemic That Never Was: Policy-Making and The Swine Flu Affair. New York: Vintage Books; 1983.

44.

Langmuir

A.D.

, Bregman

D.J.

, Kurland

L.T.

An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol. 1984; 119: 841–79.

45.

Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine–United States, 1998–1999. MMWR. 1999; 48: 577–81.

46.

van den Oever

, de Graeve

, Hepp

Pharmacoeconomics of immunisation: A review. PharmacoEconomics. 1993; 3: 286–308.

Immunization from the Perspective of a Millennium

Abstract

Credit

Objectives

Keywords

Get full access to this article

References